2017
DOI: 10.1016/bs.irn.2017.06.006
|View full text |Cite
|
Sign up to set email alerts
|

Orexin/Hypocretin System: Role in Food and Drug Overconsumption

Abstract: The neuropeptide orexin/hypocretin (OX), while largely transcribed within the hypothalamus, is released throughout the brain to affect complex behaviors. Primarily through the hypothalamus itself, OX homeostatically regulates adaptive behaviors needed for survival, including food intake, sleep-wake regulation, mating, and maternal behavior. However, through extra-hypothalamic limbic brain regions, OX promotes seeking and intake of rewarding substances of abuse, like palatable food, alcohol, nicotine, and cocai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
31
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 51 publications
(33 citation statements)
references
References 202 publications
2
31
0
Order By: Relevance
“…Since that time, now twenty years ago, hundreds of articles have followed up on this idea in numerous species, confirming the involvement of OX in normal eating and extending the findings to excessive intake of palatable foods (Barson and Leibowitz 2017). Simultaneously, researchers have identified an important role for OX in other behaviors such as the promotion of waking as well as drug seeking (Barson and Leibowitz 2017, Mahler et al 2014, Mieda 2017. With its varied behavioral effects, the precise underlying role of OX remains elusive.…”
Section: Introductionmentioning
confidence: 95%
See 2 more Smart Citations
“…Since that time, now twenty years ago, hundreds of articles have followed up on this idea in numerous species, confirming the involvement of OX in normal eating and extending the findings to excessive intake of palatable foods (Barson and Leibowitz 2017). Simultaneously, researchers have identified an important role for OX in other behaviors such as the promotion of waking as well as drug seeking (Barson and Leibowitz 2017, Mahler et al 2014, Mieda 2017. With its varied behavioral effects, the precise underlying role of OX remains elusive.…”
Section: Introductionmentioning
confidence: 95%
“…In the very first papers describing its discovery, the neuropeptide, orexin/hypocretin (OX), was suggested to play a major role in food intake and energy homeostasis (de Lecea et al 1998, Sakurai et al 1998. Since that time, now twenty years ago, hundreds of articles have followed up on this idea in numerous species, confirming the involvement of OX in normal eating and extending the findings to excessive intake of palatable foods (Barson and Leibowitz 2017). Simultaneously, researchers have identified an important role for OX in other behaviors such as the promotion of waking as well as drug seeking (Barson and Leibowitz 2017, Mahler et al 2014, Mieda 2017.…”
Section: Introductionmentioning
confidence: 98%
See 1 more Smart Citation
“…Repeated OrxR inhibition may cause nonspecific side effects by influencing numerous neural pathways. Dysfunctions of the Orx system can cause narcolepsy [65][66][67], while pharmacological manipulations of the Orx system can have nonspecific side effects on food intake [68][69][70], inhibitory responses [71][72][73], and learning and memory [74][75][76]. Such untoward effects need to be considered when investigating the clinical potential of OrxR antagonist treatment.…”
Section: The Orexin System and Substance Use Disordermentioning
confidence: 99%
“…Hypocretin signaling is necessary for the regulation of sleep cycles (Nishino et al, 2000;Thannickal et al, 2000) in addition to playing an important role in feeding (Haynes et al, 2000;Inutsuka et al, 2014) and mating (Muschamp et al, 2007) behaviors. Furthermore, hypocretin has also been implicated in behaviors of overconsumption, including substance use disorders (Barson and Leibowitz, 2017). For a current review on hypocretin receptors, please see Wang et al (2018).…”
Section: Hypocretin Receptor Antagonistsmentioning
confidence: 99%